Comparative Pharmacology
Head-to-head clinical analysis: DEXASPORIN versus TRIACET.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXASPORIN versus TRIACET.
DEXASPORIN vs TRIACET
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dexasporin is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It binds to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of pro-inflammatory mediators such as prostaglandins and leukotrienes.
Triacetin is a triester of glycerol and acetic acid. Its exact mechanism of action is not fully understood, but it exhibits antifungal activity by disrupting fungal cell membrane integrity and inhibiting fungal growth.
1 to 2 mg/kg intramuscular or intravenous every 8 hours.
0.5-1 mg orally three times daily; maximum dose 4 mg/day.
None Documented
None Documented
3-4 hours (prolonged to 10-15 hours in renal impairment; monitor CrCl <30 mL/min)
Terminal elimination half-life is approximately 3.5–4 hours in adults with normal renal function; may be prolonged (up to 6–8 hours) in patients with hepatic impairment.
Renal excretion (80-90% unchanged), biliary/fecal (10-20%)
Renal, unchanged drug: <1% of dose; metabolites: approximately 20% in urine, remainder in feces via biliary elimination.
Category C
Category C
Corticosteroid/Antibiotic Combination
Corticosteroid